Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?

To: Brander who wrote (709)	6/9/1998 10:17:00 PM
From: Bill Wexler	Read Replies (2) \| Respond to of 834

Nice try Brad...but not quite. You are taking that statement out of context. I was simply responding to YOUR post #404...where you ask: <<Bill, are you saying that SmithKline Beecham is part of the scam, or have they been scamed by TXB. Also, are you saying the FDA has also been scamed by TXB?>> And I responded that "the FDA has nothing to do with this one way or the other". You understood perfectly well my meaning that even though this company is a fraud, that the FDA does not make that determination - it only approves or disapproves new drug submissions. In post 703 I was stating that the FDA's approval or disapproval of the drug application is what counts. Not some investor's notion that a drug should be approved. My logic is correct and I continue to be 100% correct about the TXB fraud and continue to recommend shorting it. I am also 100% correct about the related Zonagen fraud and continue to recommend shorting it.